Improving interMediAte risk management. MARK study

Ruth Martí1, Dídac Parramon, Luís García-Ortiz

  • 1Unitat d'Investigació en Atenció Primària de Girona, IDIAP Jordi Gol, Institut Català de la Salut 11, Girona 17071, Espanya.

Insights

This study investigates if arterial stiffness, glucose levels, and comorbidities improve cardiovascular risk prediction in intermediate-risk patients. Findings aim to enhance early detection and prevention strategies for vascular events.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Current cardiovascular risk functions inadequately identify over 50% of patients who develop cardiovascular disease, particularly those at intermediate risk.
  • Clinical management of intermediate-risk patients is challenging due to prediction limitations.

Purpose of the Study:

  • To determine if ankle-brachial index (ABI), arterial stiffness measures, postprandial glucose, glycosylated hemoglobin, self-measured blood pressure, and comorbidities are independently associated with vascular events.
  • To assess if these factors can enhance the predictive capacity of existing risk equations in intermediate-risk populations.

Main Methods:

  • A multicenter cohort of 2688 intermediate-risk patients without prior atherosclerotic disease was recruited.
  • Data collected included socio-demographics, lifestyle, comorbidities, ABI, arterial stiffness (pulse wave velocity, cardio ankle vascular index), blood pressure, and metabolic markers (lipids, glucose, HbA1c).
  • Patients were followed for 18 months, with longer-term follow-ups planned, to ascertain the incidence of vascular events.

Main Results:

  • Analysis will determine the independent association of proposed risk factors with vascular event incidence.
  • The study will evaluate the improvement in risk prediction when these factors are added to current risk equations.

Conclusions:

  • Improving cardiovascular disease risk prediction is crucial for effective primary prevention and public health.
  • Enhanced risk stratification in intermediate-risk populations can lead to timely and efficient implementation of preventive measures.
  • This research has the potential for immediate clinical and public health impact by refining risk assessment strategies.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...